Exact Sciences
EXAS
$46.18
Share price
1.38%
Change (1 day)
-44.60%
Change (1 year)
Categories
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.
Market capitalization of Exact Sciences (EXAS)
Market cap: $8.20 Billion
As of December 2022 Exact Sciences has a market cap of $8.20 Billion. This makes Exact Sciences the world's 1653th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Exact Sciences from 2001 to 2022
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2022 | $8.20 B | -39.3% |
| 2021 | $13.51 B | -32.18% |
| 2020 | $19.92 B | 45.98% |
| 2019 | $13.65 B | 75.63% |
| 2018 | $7.77 B | 23.57% |
| 2017 | $6.29 B | 334.33% |
| 2016 | $1.44 B | 62.32% |
| 2015 | $0.89 B | -63.31% |
| 2014 | $2.43 B | 191.21% |
| 2013 | $0.83 B | 23.39% |
| 2012 | $0.67 B | 57.47% |
| 2011 | $0.42 B | 37.78% |
| 2010 | $0.31 B | 159.03% |
| 2009 | $0.12 B | 675.37% |
| 2008 | $15.53 M | -82.23% |
| 2007 | $87.39 M | 15.32% |
| 2006 | $75.78 M | 29.71% |
| 2005 | $58.42 M | -41.97% |
| 2004 | $0.10 B | -48.48% |
| 2003 | $0.19 B | -5.4% |
| 2002 | $0.20 B | 7.42% |
| 2001 | $0.19 B |
End of Day market cap according to different sources
On Dec 6th, 2022 the market cap of Exact Sciences was reported to be:
$7.95 Billion
$8.20 Billion
$8.20 Billion
$8.20 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $124.84 B | 1,421.46% | 🇫🇷 France |
 Veracyte VCYT | $2.09 B | -74.44% | 🇺🇸 USA |
 Antares Pharma ATRS | $0.95 B | -88.36% | 🇺🇸 USA |
 Myriad Genetics MYGN | $1.58 B | -80.73% | 🇺🇸 USA |
 Biocept
BIOC | $12.11 M | -99.85% | 🇺🇸 USA |